Clinical Operations SOPs, Forms & Trackers
Audit-ready, sponsor-side quality systems — SOPs, forms, and trackers, cross-referenced and aligned to current ICH E6(R3) 2025 and 21 CFR Part 11 standards.
ICH E6(R3) Implementation Guide
A plain-language implementation guide for the revised ICH E6(R3) Good Clinical Practice guideline (effective 23 July 2025 in the EU; Annex 2 Data Governance effective 15 January 2027). Learn what actually changed versus E6(R2), the five structural shifts that catch teams off guard, and a step-by-step roadmap to operationalize Quality by Design, proportionality, risk-based monitoring, and data governance. Includes a directional Appendix B protocol outline. The full Astrid-validated protocol template is available as a bundled upgrade.
The teaching guide — what changed and how to implement it.
- 10-chapter plain-language implementation guide
- What changed in E6(R3) vs E6(R2)
- The 5 structural shifts explained
- Directional Appendix B protocol outline
- 90-day implementation roadmap
- Gap self-assessment checklist
- Points to the full protocol template for upgrade
The guide plus the complete, ready-to-populate protocol template.
- Everything in the Implementation Guide
- Full ICH E6(R3) Appendix B protocol template (B.1–B.16)
- Critical-to-Quality (CtQ) factor table
- KRI / Quality Tolerance Limit table
- Schedule of Activities (SoA) table
- Annex 2 data governance section built in
- Editable Word source — populate and go
Everything plus a working session with a senior advisor.
- Everything in Guide + Full Protocol Template
- 1-hour implementation working session
- CtQ factor mapping for one of your studies
- Risk-based monitoring transition roadmap
- Annex 2 data governance gap review
- Vendor oversight model alignment
What's in the E6(R3) Guide
Every document cross-references its governing SOPs and forms — a true quality system, not a loose template pack.
- E6R3-CH-01What Actually Changed in E6(R3) vs E6(R2) — Plain Language
- E6R3-CH-02The 5 Structural Shifts That Catch Teams Off Guard
- E6R3-CH-03Quality by Design & Critical-to-Quality (CtQ) Factors — How to Identify Them
- E6R3-CH-04Proportionality — Right-Sizing Your Quality Approach
- E6R3-CH-05Risk-Based Monitoring — From 100% SDV to a Risk-Tolerant Strategy
- E6R3-CH-06Annex 2 Data Governance — The January 2027 Deadline and What It Demands
- E6R3-CH-07Sponsor Oversight & CRO/Vendor Delegation — Who Is Accountable for What
- E6R3-CH-08The Appendix B Protocol Structure — Section-by-Section Outline
- E6R3-CH-09Implementation Roadmap — 90-Day Operationalization Plan
- E6R3-CH-10Gap Self-Assessment Checklist — Where Are You Today?
- B-01B.1 General Information
- B-02B.2 Background Information
- B-03B.3 Trial Objectives and Purpose
- B-04B.4 Trial Design (embeds QbD / CtQ factors)
- B-05B.5 Selection of Participants
- B-06B.6 Discontinuation & Withdrawal
- B-07B.7 Treatment and Interventions
- B-08B.8 Assessment of Efficacy
- B-09B.9 Assessment of Safety
- B-10B.10 Statistical Considerations
- B-11B.11 Direct Access to Source Records
- B-12B.12 Quality Control & Assurance (embeds RBM + oversight)
- B-13B.13 Ethics
- B-14B.14 Data Handling & Record Keeping (embeds Annex 2)
- B-15B.15 Financing and Insurance
- B-16B.16 Publication Policy
- E6R3-IMPL-01Map your current SOPs to the E6(R3) Principles (gap analysis)
- E6R3-IMPL-02Define CtQ factors for your active studies
- E6R3-IMPL-03Transition your monitoring plan to a risk-based model
- E6R3-IMPL-04Assess computerized systems against Annex 2 data governance
- E6R3-IMPL-05Update vendor oversight agreements and escalation paths
- E6R3-IMPL-06Re-trudy teams on the proportionality mindset
- E6R3-IMPL-07Update protocol templates to the Appendix B + E6(R3) structure
- E6R3-IMPL-08Establish KRI/QTL thresholds and review cadence
The BleuConsult library vs. a leading industry SOP package
Most commercial SOP packages stop at policy documents for one audience. Ours is a complete, cross-referenced quality system — SOPs, the operational forms that execute them, and the tracker workbooks that measure them — already aligned to the current standard.
| Capability | Competitor SOP package | BleuConsult library |
|---|---|---|
| SOPs | 24 (+2 policy) | 97 across 3 suites |
| Operational forms | Not included | 165 cross-referenced |
| Tracker workbooks | Not included | 45 (5-sheet each) |
| Functional coverage | 1 sponsor-outsourced bundle | 3 dedicated suites (CDM, ClinOps, CPROG) |
| ICH GCP alignment | E6(R2) | E6(R3) 2025 |
| 21 CFR Part 11 | Partial | Built-in |
| Pricing | Hidden — request a quote | Transparent, self-serve tiers |
| Delivery | Bulk document drop | Tiered: Single → Pack → Suite → Advisory |
SOPs
Operational forms
Tracker workbooks
Functional coverage
ICH GCP alignment
21 CFR Part 11
Pricing
Delivery
Comparison reflects publicly available information about a leading commercial sponsor SOP package as of July 2026. Competitor product scope and pricing may change.
BleuConsult vs. CluePoints
CluePoints is a strong RBQM software platform for detecting risk in trial data. BleuConsult is a clinical operations advisory & readiness firm. They are complementary — but if you are deciding where to start, here is an honest comparison.
Central statistical monitoring, site risk scoring (SPOT), and intelligent query detection. Best when your data, governance, and decision owners are already in place.
Operational readiness assessments, protocol review, SOPs/governance, and the human judgment that turns a risk signal into a defensible, documented decision.
| Dimension | CluePoints | BleuConsult |
|---|---|---|
| What it is | RBQM software platform (SaaS) | Clinical operations advisory + readiness + quality-system library |
| Core capability | Statistical risk detection & site scoring on your trial data | Operational readiness, protocol review, SOPs/governance, human judgment |
| Who it serves best | Sponsors/CROs with data flowing & infrastructure to feed a platform | Early-stage biotech & investigator teams before or alongside a platform |
| ICH E6(R3) coverage | Operationalizes KRI/QTL monitoring & evidence trail | Builds the SOPs, governance, escalation pathways the tool's outputs flow through |
| Risk signal → action | Detects the signal; team must still decide & document | Advises whether the signal is clinically meaningful & operationally actionable |
| Pre-pilot readiness | Assumes data, governance & decision owners are in place | Assesses & closes readiness gaps BEFORE a platform will be viable |
| Quality-system documents | Not provided (platform, not a document library) | 97 SOPs + 165 forms + 45 trackers across CDM, ClinOps & CPROG |
| Protocol / feasibility review | Not a core offering | oPoS risk scoring & protocol review with remediation roadmap |
| Delivery model | Software subscription + implementation services | Tiered advisory engagements + self-serve document tiers ($500 entry) |
| Pricing transparency | Request a quote / enterprise sales | Published, self-serve tiers |
What it is
Core capability
Who it serves best
ICH E6(R3) coverage
Risk signal → action
Pre-pilot readiness
Quality-system documents
Protocol / feasibility review
Delivery model
Pricing transparency
How they fit together: BleuConsult gets your team ready — the SOPs, governance, decision owners, and escalation pathways — so a platform like CluePoints produces actionable, inspection-ready outcomes instead of orphan alerts. Many teams use both: BleuConsult to build the operational foundation, then a RBQM platform to monitor at scale.
Comparison reflects publicly available information about CluePoints as of August 2026. Competitor product scope and pricing may change.
After purchase, your editable Word and Excel source files are delivered by email within 1 business day. Advisory tiers include a scheduled working session with a senior advisor.
Templates are drafted for customization to your QMS, vendor model, therapeutic area, systems, and local regulatory scope. They are not a substitute for QA and legal review.
Questions? Contact our team at sales@bleuconsult.org.
Proprietary & Confidential. © 2026 BleuConsult. This content — including assessment frameworks, methodologies, and library materials — is the intellectual property of BleuConsult and is provided solely for the authorized recipient's internal use. It may not be reproduced, distributed, shared, or used to build derivative works without written permission from BleuConsult.
Compliance & Transparency
oPoS is an advisory decision-support tool designed to assist clinical trial planning. It does not replace professional regulatory judgment. The methodology is designed to support ICH E6(R3)-aligned assessment, sponsor oversight documentation, and decision evidence. The platform may process business contact information, uploaded protocol materials, and other user-provided content. Do not upload PHI unless appropriate agreements and safeguards are in place. VeriAbyss™ provides AI-assisted consistency review; outputs remain advisory until qualified human review.
© 2026 BleuConsult. All methodologies, frameworks, assessment logic, and library materials are the proprietary intellectual property of BleuConsult. All rights reserved.
All assessments are for informational purposes only.
